Recent neuropathological findings in MS--implications for diagnosis and therapy
Related Experiment Video
Updated: Aug 22, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
1Brain Research Institute, University of Vienna, Division of Neuroimmunology, Spitalgasse 4, 1090, Vienna, Austria. hans.lassmann@univie.ac.at
Abstract:
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system, associated with primary destruction of myelin sheaths. Axons are relatively well preserved, although they too are injured in the development of the lesions. While inflammation and demyelination induce neurological deficit, which is in part reversible, the destruction of axons, when past the threshold of compensation, is always accompanied by irreversible clinical deficits. The mechanisms leading to tissue injury in MS are complex and heterogenous. They involve direct cytotoxicity mediated by T-lymphocytes, specific antibodies and complement as well as toxic products of macrophages. In addition, in a small subset of patients a genetically determined increased susceptibility of the central nervous system tissue for immune mediated damage appears to play a role. Since the pathogenetic pathways of demyelination and tissue damage vary between different MS patients, their identification by paraclinical markers is of critical importance for diagnosis and therapeutic management.
Insights
Multiple sclerosis (MS) involves central nervous system inflammation and myelin destruction. Identifying diverse damage pathways is crucial for effective diagnosis and treatment of this complex neurological disease.
Area of Science:
- Neuroimmunology
- Neuropathology
Background:
- Multiple sclerosis (MS) is a chronic central nervous system inflammatory disease.
- MS primarily targets myelin sheaths, but also causes axonal injury.
- Neurological deficits in MS can be reversible (demyelination) or irreversible (axonal loss).
Purpose of the Study:
- To elucidate the complex and heterogeneous mechanisms of tissue injury in MS.
- To highlight the importance of identifying distinct pathogenetic pathways in MS patients.
- To underscore the critical role of paraclinical markers for diagnosis and therapeutic management.
Main Methods:
- The study reviews existing literature on MS pathogenesis.
- Mechanisms discussed include T-lymphocyte cytotoxicity, antibody and complement involvement, and macrophage-derived toxins.
- Genetic susceptibility to immune-mediated damage is also considered.
Main Results:
- Tissue injury in MS results from a combination of immune-mediated attacks.
- Axonal destruction, beyond a certain threshold, leads to permanent neurological deficits.
- Individual variations in pathogenetic pathways exist among MS patients.
Conclusions:
- Understanding the diverse mechanisms of demyelination and tissue damage is vital.
- Paraclinical markers are essential for personalized diagnosis and treatment strategies in MS.
- Targeting specific pathogenetic pathways may improve therapeutic outcomes.
More Related Videos
12:23Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
09:46Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
Related Concept Videos
Multiple Sclerosis l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology
Parkinson's Disease: Overview
Parkinson Disease ll: Pathophysiology